580 related items for PubMed ID: 25778686
1. A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease.
Ye Q, Shao WX, Shang SQ, Zhang T, Hu J, Zhang CC.
Arthritis Rheumatol; 2015 Jul; 67(7):1943-50. PubMed ID: 25778686
[Abstract] [Full Text] [Related]
2. [Prediction of the risk of coronary arterial lesions in Kawasaki disease by N-terminal pro-brain natriuretic peptide].
Huiling L, Yaping L, Xiufen H.
Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):300-3. PubMed ID: 26182507
[Abstract] [Full Text] [Related]
3. Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease.
Kitoh T, Ohara T, Muto T, Okumura A, Baba R, Koizumi Y, Yamagishi Y, Mikamo H, Daigo K, Hamakubo T.
Front Immunol; 2021 Apr; 12():624802. PubMed ID: 33912155
[Abstract] [Full Text] [Related]
4. N-terminal pro-brain natriuretic peptide and risk of coronary artery lesions and resistance to intravenous immunoglobulin in Kawasaki disease.
Yoshimura K, Kimata T, Mine K, Uchiyama T, Tsuji S, Kaneko K.
J Pediatr; 2013 Jun; 162(6):1205-9. PubMed ID: 23290510
[Abstract] [Full Text] [Related]
5. The role of age-specific N-terminal pro-brain natriuretic peptide cutoff values in predicting intravenous immunoglobulin resistance in Kawasaki disease: a prospective cohort study.
Shao S, Luo C, Zhou K, Hua Y, Wu M, Liu L, Liu X, Wang C.
Pediatr Rheumatol Online J; 2019 Sep 18; 17(1):65. PubMed ID: 31533770
[Abstract] [Full Text] [Related]
6. Value of amino-terminal pro B-natriuretic peptide in diagnosing Kawasaki disease.
McNeal-Davidson A, Fournier A, Spigelblatt L, Saint-Cyr C, Mir TS, Nir A, Dallaire F, Cousineau J, Delvin E, Dahdah N.
Pediatr Int; 2012 Oct 18; 54(5):627-33. PubMed ID: 22414326
[Abstract] [Full Text] [Related]
7. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
Xie T, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F.
Pediatr Rheumatol Online J; 2017 Mar 21; 15(1):17. PubMed ID: 28320400
[Abstract] [Full Text] [Related]
8. Pro-brain natriuretic peptide (ProBNP) levels in North Indian children with Kawasaki disease.
Reddy M, Singh S, Rawat A, Sharma A, Suri D, Rohit MK.
Rheumatol Int; 2016 Apr 21; 36(4):551-9. PubMed ID: 26849890
[Abstract] [Full Text] [Related]
9. Adjuvant laboratory marker of Kawasaki disease; NT-pro-BNP or hs-CRP?
Cho SY, Kim Y, Cha SH, Suh JT, Han MY, Lee HJ.
Ann Clin Lab Sci; 2011 Apr 21; 41(4):360-3. PubMed ID: 22166506
[Abstract] [Full Text] [Related]
10. Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm.
Wu Y, Liu FF, Xu Y, Wang JJ, Samadli S, Wu YF, Liu HH, Chen WX, Luo HH, Zhang DD, Wei W, Hu P.
Clin Exp Med; 2019 May 21; 19(2):173-181. PubMed ID: 30617865
[Abstract] [Full Text] [Related]
11. N-terminal pro-B-type natriuretic peptide diagnostic algorithm versus American Heart Association algorithm for Kawasaki disease.
Dionne A, Meloche-Dumas L, Desjardins L, Turgeon J, Saint-Cyr C, Autmizguine J, Spigelblatt L, Fournier A, Dahdah N.
Pediatr Int; 2017 Mar 21; 59(3):265-270. PubMed ID: 27589358
[Abstract] [Full Text] [Related]
12. N-terminal pro-brain natriuretic peptide can be an adjunctive diagnostic marker of hyper-acute phase of Kawasaki disease.
Kwon H, Lee JH, Jung JY, Kwak YH, Kim DK, Jung JH, Chang I, Kim K.
Eur J Pediatr; 2016 Dec 21; 175(12):1997-2003. PubMed ID: 27798729
[Abstract] [Full Text] [Related]
13. Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki disease.
Dahdah N, Siles A, Fournier A, Cousineau J, Delvin E, Saint-Cyr C, Spiegelblatt L, Bonny Y, Vartian M, Montigny M.
Pediatr Cardiol; 2009 Aug 21; 30(6):810-7. PubMed ID: 19365652
[Abstract] [Full Text] [Related]
14. Cardiac function on 3-D speckle tracking imaging and cytokines in Kawasaki disease.
Kato M, Ayusawa M, Watanabe H, Komori A, Abe Y, Nakamura T, Kamiyama H, Takahashi S.
Pediatr Int; 2018 Apr 21; 60(4):342-348. PubMed ID: 29350882
[Abstract] [Full Text] [Related]
15. [Change in plasma N-terminal pro-brain natriuretic peptide in children with Kawasaki disease and its value in clinical practice].
Zhang QY, Du JB, Chen YH, Li WZ.
Zhonghua Er Ke Za Zhi; 2006 Dec 21; 44(12):886-90. PubMed ID: 17254452
[Abstract] [Full Text] [Related]
16. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients.
Sato S, Kawashima H, Kashiwagi Y, Hoshika A.
Int J Rheum Dis; 2013 Apr 21; 16(2):168-72. PubMed ID: 23773640
[Abstract] [Full Text] [Related]
17. N-terminal pro-brain natriuretic peptide (NT proBNP) as a predictive indicator of initial intravenous immunoglobulin treatment failure in children with Kawasaki disease: a retrospective study.
Kim SY, Han MY, Cha SH, Jeon YB.
Pediatr Cardiol; 2013 Apr 21; 34(8):1837-43. PubMed ID: 23744100
[Abstract] [Full Text] [Related]
18. Usefulness of Age-Stratified N-Terminal Prohormone of Brain Natriuretic Peptide for Diagnosing Kawasaki Disease.
Lee SH, Song ES, Yoon S, Hong S, Cho HJ, Yang EM, Eom GH, Kang G, Cho YK.
Dis Markers; 2017 Apr 21; 2017():6263121. PubMed ID: 29358841
[Abstract] [Full Text] [Related]
19. Usefulness of age-adjusted N-terminal prohormone of brain natriuretic peptide level as a diagnostic marker for incomplete Kawasaki disease in children.
Rodríguez-González M, Castellano-Martínez A, Alonso-Ojembarrena A.
Emergencias; 2017 Apr 21; 31(2):111-114. PubMed ID: 30963739
[Abstract] [Full Text] [Related]
20. A comparative study of IL-6, CRP and NT-proBNP levels in post-COVID multisystem inflammatory syndrome in children (MISC) and Kawasaki disease patients.
Ganguly M, Nandi A, Banerjee P, Gupta P, Sarkar SD, Basu S, Pal P.
Int J Rheum Dis; 2022 Jan 21; 25(1):27-31. PubMed ID: 34750969
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
